Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors-Reference-Cited by-同舟云学术

Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors

Published:2018-08-21 Issue:11 Volume:14 Page:945-956
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Atzeni Fabiola¹,Talotta Rossella²,Nucera Valeria¹,Marino Francesca¹,Gerratana Elisabetta¹,Sangari Donatella¹,Masala Ignazio Francesco³,Sarzi-Puttini Piercarlo⁴

Affiliation:

1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

2. Department of Clinical Pharmacology and Toxicology, University of Milan, Laboratory of Genetics, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

3. Orthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy

4. Rheumatology Unit, Department of Internal Medicine, ASST-Fatebenefratelli L. Sacco University Hospital, Milan, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2018.1504678

Reference72 articles.

1. Therapeutic Targeting of the JAK/STAT Pathway